medigraphic.com
ISSN 2448-8909 (Print)

2024, Number 2

<< Back

Med Crit 2024; 38 (2)

Inhaled anesthetic in status asthmatics, experience of two cases

Carrillo-Esper R, Velarde PAA

Language: Spanish
References: 36
Page: 134-143
PDF size: 375.63 Kb.


ABSTRACT

Introduction: status asthmaticus is characterized by being an episode of asthmatic crisis due to persistent inflammation, which has a poor response to standard treatment and is life-threatening. This disease, due to its pathophysiology, is time dependent on its timely recognition and early treatment. Clinical cases: this paper describes two cases of female patients who required admission to the Intensive Care Unit, due to status asthmaticus refractory to conventional treatment, where volatile anesthetics (sevoflurane) administered through the inhaled sedation device with the AnaConDa (Anesthetic Conserving Device) were used, achieving adequate resolution of the bronchospasm due to the effect of these drugs on bronchial smooth muscle and inflammation. Conclusion: the volatile anesthetic drugs administered through this device, favor bronchodilatation, improvement in airflow, resolution of hypercapnia without significantly affecting dead space, improving the efficiency of the response to bronchodilator and anti-inflammatory treatment, with a sparing effect on sedatives. Therefore, the management of inhaled anesthetics through the AnaConDa device is a useful alternative for managing asthmatic status.


REFERENCES

  1. Rodrigo C. Asma aguda severa: su manejo en la emergencia y cuidado intensivo. Med Intensiva [Internet]. 2006;30(9):460-470. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-56912006000900007&lng=es

  2. GEMA 4.4 — Guía española para el manejo del asma. Madrid: Comité Ejecutivo de la GEMA; 2019.

  3. Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896-902. doi: 10.1016/j.jaci.2014.08.042.

  4. Gaviria S, Ramírez A, Alzate M, Contreras H, Jaramillo N, Muñoz MC. Epidemiología del síndrome coronario agudo. Med UPB. 2020;39(1):49-56. doi: 10.18566/medupb.v39n1.a08.

  5. Chakraborty RK, Basnet S. Status asthmaticus. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526070/

  6. Garner O, Ramey JS, Hanania NA. Management of life-threatening asthma: severe asthma series. Chest. 2022;162(4):747-756. doi: 10.1016/j.chest.2022.02.029.

  7. Lin MP, Vargas-Torres C, Schuur JD, Shi D, Wisnivesky J, Richardson LD. Trends and predictors of hospitalization after emergency department asthma visits among U.S. Adults, 2006-2014. J Asthma. 2020;57(8):811-819. doi: 10.1080/02770903.2019.1621889.

  8. Maselli DJ, Peters JI. Medication regimens for managing acute asthma. Respir Care. 2018;63(6):783-796. doi: 10.4187/respcare.05953.

  9. Long B, Lentz S, Koyfman A, Gottlieb M. Evaluation and management of the critically ill adult asthmatic in the emergency department setting. Am J Emerg Med. 2021;44:441-451. doi: 10.1016/j.ajem.2020.03.029.

  10. Beitler JR, Talmor D. Volatile anesthetics for ICU sedation: the future of critical care or niche therapy? Intensive Care Med. 2022;48(10):1413-1417. doi: 10.1007/s00134-022-06842-7.

  11. Carrillo-Esper R, Velarde Pineda AA, Zepeda Mendoza AD, Arellano Ramírez A, Pérez Calatayud A, Mendoza Popoca CU, et al. Documento de posicionamiento: uso de sedación inhalada en el paciente críticamente enfermo. Med Crit. 2022;36(Suppl: 2):s43-64. doi: 10.35366/107394.

  12. Binachon A, Grateau A, Allou N, Ferdynus C, Allyn J, Dangers L, et al. Acute severe asthma requiring invasive mechanical ventilation in the era of modern resuscitation techniques: A 10-year bicentric retrospective study. PLoS One. 2020;15(10):e0240063. doi: 10.1371/journal.pone.0240063.

  13. King GG, James A, Harkness L, Wark PAB. Pathophysiology of severe asthma: We've only just started. Respirology. 2018;23(3):262-271.

  14. Habib N, Pasha MA, Tang DD. Current understanding of asthma pathogenesis and biomarkers. Cells. 2022;11(17):2764. doi: 10.3390/cells11172764.

  15. Kostakou E, Kaniaris E, Filiou E, Vasileiadis I, Katsaounou P, Tzortzaki E, et al. Acute severe asthma in adolescent and adult patients: current perspectives on assessment and management. J Clin Med. 2019;8(9):1283. doi: 10.3390/jcm8091283.

  16. Lin J, Xing B, Chen P, Huang M, Zhou X, Wu C, et al. Chinese expert consensus-based guideline on assessment and management of asthma exacerbation. J Thorac Dis. 2019;11(12):4918-4935.

  17. Laher AE, Buchanan SK. Mechanically ventilating the severe asthmatic. J Intensive Care Med. 2018;33(9):491-501.

  18. Geng W, Batu W, You S, Tong Z, He H. High-flow nasal cannula: a promising oxygen therapy for patients with severe bronchial asthma complicated with respiratory failure. Can Respir J. 2020;2020:2301712.

  19. Miller K, Stowe J, Bedekovich A. The utilization of venous-venous extracorporeal membrane oxygenation for the management of status asthmaticus. Respiratory Care. 2018;63:3003779.

  20. Vaschetto R, Bellotti E, Turucz E, Gregoretti C, Corte FD, Navalesi P. Inhalational anesthetics in acute severe asthma. Curr Drug Targets. 2009;10(9):826-832.

  21. Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ. 1989;298(6683):1277-1280.

  22. Mondoñedo JR, McNeil JS, Amin SD, Herrmann J, Simon BA, Kaczka DW. Volatile anesthetics and the treatment of severe bronchospasm: a concept of targeted delivery. Drug Discov Today Dis Models. 2015;15:43-50.

  23. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol. 2005;19(3):523-538.

  24. O'Rourke PP, Crone RK. Halothane in status asthmaticus. Crit Care Med. 1982;10(5):341-343.

  25. Gorsky K, Cuninghame S, Chen J, Jayaraj K, Withington D, Francoeur C, et al. Use of inhalational anaesthetic agents in paediatric and adult patients for status asthmaticus, status epilepticus and difficult sedation scenarios: a protocol for a systematic review. BMJ Open. 2021;11(11):e051745.

  26. Wigmore T, Stachowski E. A review of the use of heliox in the critically ill. Crit Care Resusc. 2006;8(1):64-72.

  27. Farrell R, Oomen G, Carey P. A technical review of the history, development and performance of the anaesthetic conserving device "AnaConDa" for delivering volatile anaesthetic in intensive and post-operative critical care. J Clin Monit Comput. 2018;32(4):595-604.

  28. Ruszkai Z, Bokrétás GP, Bartha PT. Sevoflurane therapy for life-threatening acute severe asthma: a case report. Can J Anaesth. 2014;61(10):943-950.

  29. Keenan LM, Hoffman TL. Refractory status asthmaticus: treatment with sevoflurane. Fed Pract. 2019;36(10):476-479.

  30. Álvarez MP, Hernández RG, Valdes EGD, Navarro RF, Casillas SC, Hernández SA. Minimización de costos de sedación usando anestesia inhalada. Análisis en la UTI durante la pandemia por COVID-19. Med Crit. 2023;37(2):113-116.

  31. Tobias JD. Inhalational anesthesia: basic pharmacology, end organ effects, and applications in the treatment of status asthmaticus. J Intensive Care Med. 2009;24(6):361-371.

  32. Gill B, Bartock JL, Damuth E, Puri N, Green A. Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation. Front Med (Lausanne). 2022;9:1051468.

  33. Zaidi SR, Blakey JD. Why are people with asthma susceptible to pneumonia? A review of factors related to upper airway bacteria. Respirology. 2019;24(5):423-430.

  34. Jabaudon M, Zhai R, Blondonnet R, Bonda WLM. Inhaled sedation in the intensive care unit. Anaesth Crit Care Pain Med. 2022;41(5):101133.

  35. Meiser A, Volk T, Wallenborn J, Guenther U, Becher T, Bracht H, et al. Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial. Lancet Respir Med. 2021;9(11):1231-1240.

  36. Plans-Galván O, Daniel X, Rosich S, Blázquez-Alcaide V, Gil-Castillejos D, Bodí M. Use of isoflurane as treatment for super-refractory status epilepticus. Rev Neurol. 2023;76(9):309-312.




2020     |     www.medigraphic.com